Advertisement

Advertisement

DARE Stock Latest News

Daré Bioscience Posts Updated Corporate Investor Presentation Online

Company AnnouncementsDaré Bioscience Posts Updated Corporate Investor Presentation Online

Daré Bioscience Completes Regulation A Preferred Stock Offering

PremiumCompany Announcements

Daré Bioscience Completes Regulation A Preferred Stock Offering

15d ago

Daré Bioscience Rebalances Classified Board Structure and Terms

PremiumCompany Announcements

Daré Bioscience Rebalances Classified Board Structure and Terms

18d ago

Daré Bioscience Completes Regulation A Preferred Stock Offering

PremiumCompany Announcements

Daré Bioscience Completes Regulation A Preferred Stock Offering

22d ago

DARE Earnings this Week: How Will it Perform?

PremiumPre-Earnings

DARE Earnings this Week: How Will it Perform?

1M ago

Daré Bioscience Completes Regulation A Preferred Stock Offering

PremiumCompany AnnouncementsDaré Bioscience Completes Regulation A Preferred Stock Offering

2M ago

Dare Bioscience receives NIH funding award notice for DARE-PTB1

The Fly

Dare Bioscience receives NIH funding award notice for DARE-PTB1

2M ago

Daré Bioscience Completes Second Closing of Regulation A Offering

Company Announcements

Daré Bioscience Completes Second Closing of Regulation A Offering

2M ago

Daré Bioscience Updates Investor Presentation Under Regulation FD

PremiumCompany Announcements

Daré Bioscience Updates Investor Presentation Under Regulation FD

2M ago

Dare Bioscience announces FDA clearance of IND application for Dare-HPV

PremiumThe Fly

Dare Bioscience announces FDA clearance of IND application for Dare-HPV

2M ago

Dare announces availability of telehealth consultations for DARE to PLAY

PremiumThe Fly

Dare announces availability of telehealth consultations for DARE to PLAY

3M ago

Daré Bioscience Launches Regulation A Preferred Unit Offering

PremiumCompany Announcements

Daré Bioscience Launches Regulation A Preferred Unit Offering

3M ago

Daré Bioscience Issues Updated Investor Corporate Presentation

PremiumCompany AnnouncementsDaré Bioscience Issues Updated Investor Corporate Presentation

4M ago

Dare Bioscience announces providers in select states can prescribe DARE to PLAY

The Fly

Dare Bioscience announces providers in select states can prescribe DARE to PLAY

5M ago

Strategic Realignment and Growth Potential: Justifying a Buy Rating for Daré Bioscience

Ratings

Strategic Realignment and Growth Potential: Justifying a Buy Rating for Daré Bioscience

5M ago

Daré Bioscience Gains Full Control Over Ovaprene

PremiumCompany Announcements

Daré Bioscience Gains Full Control Over Ovaprene

5M ago

Dare Bioscience announces return of rights to Oveprene

PremiumThe Fly

Dare Bioscience announces return of rights to Oveprene

5M ago

Dare Bioscience receives $3.6M in additional grant funding

PremiumThe Fly

Dare Bioscience receives $3.6M in additional grant funding

5M ago

Daré Bioscience’s Promising Growth and Product Launches Justify Buy Rating

PremiumRatings

Daré Bioscience’s Promising Growth and Product Launches Justify Buy Rating

6M ago

Daré Bioscience’s Earnings Call Highlights Growth and Challenges

PremiumCompany AnnouncementsDaré Bioscience’s Earnings Call Highlights Growth and Challenges

6M ago

Daré Bioscience Advances Women’s Health Innovations

Company Announcements

Daré Bioscience Advances Women’s Health Innovations

6M ago

Dare Bioscience reports Q3 EPS (28c), consensus (38c)

The Fly

Dare Bioscience reports Q3 EPS (28c), consensus (38c)

6M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >